C07C211/27

MATERIALS COMPRISING CARBON-EMBEDDED NICKEL NANOPARTICLES, PROCESSES FOR THEIR MANUFACTURE, AND USE AS HETEROGENEOUS CATALYSTS

The present invention relates to catalytically active material, comprising grains of non-graphitizing carbon with nickel nanoparticles dispersed therein, wherein dp, the average diameter of nickel nanoparticles in the non-graphitizing carbon grains, is in the range of 1 nm to 20 nm, D, the average distance between nickel nanoparticles in the non-graphitizing carbon grains, is in the range of 2 nm to 150 nm, and ω, the combined total mass fraction of metal in the non-graphitizing carbon grains, is in the range of 30 wt % to 70 wt % of the total mass of the non-graphitizing carbon grains, and wherein dp, D and ω conform to the following relation: 4.5 dp/ω>D≥0.25 dp/ω. The present invention, further, relates to a process for the manufacture of material according to the invention, as well as its use as a catalyst.

MATERIALS COMPRISING CARBON-EMBEDDED NICKEL NANOPARTICLES, PROCESSES FOR THEIR MANUFACTURE, AND USE AS HETEROGENEOUS CATALYSTS

The present invention relates to catalytically active material, comprising grains of non-graphitizing carbon with nickel nanoparticles dispersed therein, wherein dp, the average diameter of nickel nanoparticles in the non-graphitizing carbon grains, is in the range of 1 nm to 20 nm, D, the average distance between nickel nanoparticles in the non-graphitizing carbon grains, is in the range of 2 nm to 150 nm, and ω, the combined total mass fraction of metal in the non-graphitizing carbon grains, is in the range of 30 wt % to 70 wt % of the total mass of the non-graphitizing carbon grains, and wherein dp, D and ω conform to the following relation: 4.5 dp/ω>D≥0.25 dp/ω. The present invention, further, relates to a process for the manufacture of material according to the invention, as well as its use as a catalyst.

Compounds for treatment of PD-L1 diseases

Compounds are provided that are useful as immunomodulators. The compounds have the Formula (I) ##STR00001##
including stereoisomers and pharmaceutically acceptable salts thereof, wherein R.sup.1a, R.sup.1b, R.sup.1c, R.sup.1d, R.sup.2a, R.sup.2b, R.sup.3, R.sup.3a, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8 and the subscript n are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

METHOD OF PRODUCING THIOURETHANE RESIN RAW MATERIAL AND APPLICATION THEREOF, METHOD OF PRODUCING POLYTHIOL COMPOSITION AND APPLICATION THEREOF, AND POLYTHIOL COMPOSITION

A method of producing a thiourethane resin raw material, the method including comprising the step of generating the thiourethane resin raw material by reacting a thiourethane resin and an active hydrogen compound with each other.

METHOD OF PRODUCING THIOURETHANE RESIN RAW MATERIAL AND APPLICATION THEREOF, METHOD OF PRODUCING POLYTHIOL COMPOSITION AND APPLICATION THEREOF, AND POLYTHIOL COMPOSITION

A method of producing a thiourethane resin raw material, the method including comprising the step of generating the thiourethane resin raw material by reacting a thiourethane resin and an active hydrogen compound with each other.

AMINOADAMANTYL NITRATE COMPOUNDS AND THEIR USE TO TREAT CNS DISORDERS

The present disclosure provides adamantyl compounds having one or more amine groups and one or more nitrate groups. The aminoadamantyl nitrate compounds can be used to treat disorders of the central nervous system, including neurodegenerative and non-neurodegenerative diseases.

AMINOADAMANTYL NITRATE COMPOUNDS AND THEIR USE TO TREAT CNS DISORDERS

The present disclosure provides adamantyl compounds having one or more amine groups and one or more nitrate groups. The aminoadamantyl nitrate compounds can be used to treat disorders of the central nervous system, including neurodegenerative and non-neurodegenerative diseases.

Bifunctional alpha-synuclein binding agents and uses thereof

Bifunctional molecules having first and second alpha-synuclein binding agents coupled by a linker are disclosed. The bifunctional molecules have potential utility in the diagnosis, treatment and/or prophylaxis of disorders in which alpha-synuclein is implicated, including Parkinson's disease. Methods of making and using the bifunctional molecules are disclosed.

MATERIALS COMPRISING CARBON-EMBEDDED IRON NANOPARTICLES, PROCESSES FOR THEIR MANUFACTURE, AND USE AS HETEROGENEOUS CATALYSTS

The present invention relates to catalytically active material, comprising grains of non-graphitizing carbon with iron nanoparticles dispersed therein, wherein d.sub.p, the average diameter of iron nanoparticles in the non-graphitizing carbon grains, is in the range of 1 nm to 20 nm, D, the average distance between iron nanoparticles in the non-graphitizing carbon grains, is in the range of 2 nm to 150 nm, and ω, the combined total mass fraction of metal in the non-graphitizing carbon grains, is in the range of 30 wt % to 70 wt % of the total mass of the non-graphitizing carbon grains, and wherein d.sub.p, D and ω conform to the following relation: 4.5 d.sub.p/ω>D≥0.25 d.sub.p/ω. The present invention, further, relates to a process for the manufacture of material according to the invention, as well as its use as a catalyst.

MATERIALS COMPRISING CARBON-EMBEDDED IRON NANOPARTICLES, PROCESSES FOR THEIR MANUFACTURE, AND USE AS HETEROGENEOUS CATALYSTS

The present invention relates to catalytically active material, comprising grains of non-graphitizing carbon with iron nanoparticles dispersed therein, wherein d.sub.p, the average diameter of iron nanoparticles in the non-graphitizing carbon grains, is in the range of 1 nm to 20 nm, D, the average distance between iron nanoparticles in the non-graphitizing carbon grains, is in the range of 2 nm to 150 nm, and ω, the combined total mass fraction of metal in the non-graphitizing carbon grains, is in the range of 30 wt % to 70 wt % of the total mass of the non-graphitizing carbon grains, and wherein d.sub.p, D and ω conform to the following relation: 4.5 d.sub.p/ω>D≥0.25 d.sub.p/ω. The present invention, further, relates to a process for the manufacture of material according to the invention, as well as its use as a catalyst.